Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

被引：0
|
作者：
Megias-Vericat, Juan Eduardo [1 ,2 ]
Marques, Maria Remedios [1 ]
Haya, Saturnino [3 ]
Cid, Ana Rosa [3 ]
Querol, Felipe [3 ]
Monte, Emilio [1 ,3 ]
Garcia-Dasi, Maria [3 ]
Caunedo, Patricia [3 ]
Vila, Carmen [3 ]
Bosch, Pau [3 ]
Curats, Rafael [3 ]
Sanz, Miguel Angel [4 ]
Poveda, Jose Luis [1 ,2 ]
Bonanad, Santiago [5 ]
机构：
[1] Hosp Univ & Politecn La Fe, Dept Pharm, Drug Clin Area, Valencia, Spain
[2] Inst Invest Sanit La Fe, Valencia, Spain
[3] Hosp Univ & Politecn La Fe, Dept Hematol, Hemostasis & Thrombosis Unit, Valencia, Spain
[4] Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain
[5] Hosp La Ribera, Alzira, Spain
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3802.3802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3802
引用
收藏
页数：4
相关论文
共 50 条
  • [31] The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update
    Lusher, JM
    Roth, DA
    HAEMOPHILIA, 2005, 11 (03) : 292 - 293
  • [32] European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients
    Rothschild, C
    Scharrer, I
    Brackmann, HH
    Stieltjes, N
    Vicariot, M
    Torchet, MF
    Effenberger, W
    HAEMOPHILIA, 2002, 8 : 10 - 14
  • [33] BAY 94-9027 and recombinant factor VIII Fc fusion protein: A head-to-head, randomized, crossover, pharmacokinetic study in patients with severe haemophilia A
    Shah, A.
    Solms, A.
    Wiegmann, S.
    Ahsman, M.
    Berntorp, E.
    Zhivkov, T.
    Lissitchkov, T.
    HAEMOPHILIA, 2019, 25 : 45 - 45
  • [34] Comparison of thrombin generation and FVIII level measurements in haemophilia patients after recombinant factor VIII treatment
    Dielis, A.
    Balliel, W.
    Ten Cate, H.
    Hamulyak, K.
    Van Oerle, R.
    Hermens, W.
    HAEMOPHILIA, 2008, 14 : 22 - 22
  • [35] Improvement of the quality of health care for children with severe haemophilia a using prophylaxis and treatment of bleeding episodes with recombinant factor VIII
    Glamocanin, S.
    Trajkova-Antevska, Z.
    Coneska, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 856 - 856
  • [36] Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
    Shapiro, A. D.
    Mahlangu, J. N.
    Perry, D.
    Pasi, J.
    Quon, D. V.
    Chowdary, P.
    Tsao, E.
    Li, S.
    Innes, A.
    Pierce, G. F.
    Allen, G. A.
    HAEMOPHILIA, 2017, 23 (03) : 392 - 399
  • [37] Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study
    Nolan, Beatrice
    Mahlangu, Johnny
    Pabinger, Ingrid
    Young, Guy
    Konkle, Barbara A.
    Barnes, Chris
    Nogami, Keiji
    Santagostino, Elena
    Pasi, K. John
    Khoo, Liane
    Winding, Bent
    Yuan, Huixing
    Fruebis, Joachim
    Rudin, Dan
    Oldenburg, Johannes
    HAEMOPHILIA, 2020, 26 (03) : 494 - 502
  • [38] Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A
    Martinowitz, U.
    Bjerre, J.
    Brand, B.
    Klamroth, R.
    Misgav, M.
    Morfini, M.
    Santagostino, E.
    Tiede, A.
    Viuff, D.
    HAEMOPHILIA, 2011, 17 (06) : 854 - 859
  • [39] Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States
    Potnis, Kunal C.
    Viswanathan, Giri
    Bona, Robert D.
    Ito, Satoko
    Kempton, Christine L.
    Pandya, Ankur
    Krumholz, Harlan M.
    Goshua, George
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (09) : E247 - E250
  • [40] Pharmacokinetic, efficacy and safety evaluation of B-domain-deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A
    Xue, Feng
    Zhao, Xielan
    Sun, Jing
    Zeng, Xiaojing
    Yang, Fenge
    Xu, Ming
    Yu, Ziqiang
    Gu, Weiying
    Feng, Ying
    Li, Wenqian
    Zheng, Changcheng
    Bi, Hui
    Xie, Liangzhi
    Gai, Wenlin
    Yang, Renchi
    HAEMOPHILIA, 2021, 27 (05) : 814 - 822
12345